Cinacalcet Tablet, Film Coated
Product Images NDC 72162-1843

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Cinacalcet (NDC 72162-1843). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cinacalcet-fig3 (Cinacalcet Fig3)

A line graph depicting serum calcium levels (mg/dL) over time in weeks for patients with parathyroid carcinoma. It includes phases labeled Titration and Maintenance, with data points from baseline (B) to week 80, showing calcium levels fluctuating around 11-13 mg/dL. The number of patients at each time point is noted below the x-axis.*

FDA Label Image

Cinacalcet-fig4.jpg (Cinacalcet Fig4)

A line graph depicting serum calcium levels (mg/dL) over weeks in a study of intractable pHPT patients. The x-axis shows time in weeks, including baseline, end of titration (EOT), and maintenance phases. Calcium levels decrease sharply after baseline, then stabilize through the maintenance period, with error bars indicating variability at each time point.*

FDA Label Image

Cinacalcet-figure-1.jpg (Cinacalcet Figure 1)

A line graph titled 'Mean (SE) iPTH Values (Pooled Phase 3 Studies)' comparing iPTH levels (pg/mL) over 26 weeks between placebo and Cinacalcet groups. The graph shows a downward trend in iPTH values for the Cinacalcet group over time, while the placebo group maintains relatively stable iPTH levels.*

FDA Label Image

Cinacalcet-figure-2 (Cinacalcet Figure 2)

A line graph titled 'Mean (SE) Ca x P Values (Pooled Phase 3 Studies)' comparing calcium-phosphorus product levels over 26 weeks between placebo and Cinacalcet groups. The y-axis shows Ca x P values (mg/dL) squared, and the x-axis represents weeks. Two lines represent the placebo group and the Cinacalcet group with plotted mean values and error bars.*

FDA Label Image

Cinacalcet-str (Cinacalcet Str)

Chemical structure of cinacalcet hydrochloride, showing the molecular arrangement including a trifluoromethyl-substituted aromatic ring, an amine group, and a methyl-substituted biphenyl moiety.*

FDA Label Image

Label (Lbl721621843)

Cinacalcet Tablets 30 mg film-coated tablets label showing the NDC 72162-1843-3. The label indicates a package size of 30 tablets and states prescription use (Rx only). It includes storage instructions, pharmacist dispensing guidance with a link to patient package inserts, and mentions Bryant Ranch Prepack as the relabeler and Alkem Laboratories Ltd as the manufacturer. The label also has barcodes and a QR code.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.